Goldman Sachs Group Inc Nanobiotix S.A. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Nanobiotix S.A. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 10,498 shares of NBTX stock, worth $43,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,498Holding current value
$43,671% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBTX
# of Institutions
19Shares Held
6.25MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$23.4 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$1.11 Million0.03% of portfolio
-
Black Rock Inc. New York, NY239KShares$994,2730.0% of portfolio
-
Old Mission Capital LLC48.5KShares$201,6510.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$96,8570.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $145M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...